DK1370513T3 - Æblesyreadditionssalte af terbinafin - Google Patents

Æblesyreadditionssalte af terbinafin

Info

Publication number
DK1370513T3
DK1370513T3 DK02704689T DK02704689T DK1370513T3 DK 1370513 T3 DK1370513 T3 DK 1370513T3 DK 02704689 T DK02704689 T DK 02704689T DK 02704689 T DK02704689 T DK 02704689T DK 1370513 T3 DK1370513 T3 DK 1370513T3
Authority
DK
Denmark
Prior art keywords
malic
terbinafine
addition salts
antimycotics
compound
Prior art date
Application number
DK02704689T
Other languages
Danish (da)
English (en)
Inventor
Danielle Giron
Jean-Louis Reber
Stefan Hirsch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1370513T3 publication Critical patent/DK1370513T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
DK02704689T 2001-02-07 2002-02-06 Æblesyreadditionssalte af terbinafin DK1370513T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0103046.9A GB0103046D0 (en) 2001-02-07 2001-02-07 Organic Compounds
PCT/EP2002/001249 WO2002070455A1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
EP02704689A EP1370513B1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine

Publications (1)

Publication Number Publication Date
DK1370513T3 true DK1370513T3 (da) 2005-08-01

Family

ID=9908301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02704689T DK1370513T3 (da) 2001-02-07 2002-02-06 Æblesyreadditionssalte af terbinafin

Country Status (27)

Country Link
US (2) US20040147603A1 (enExample)
EP (1) EP1370513B1 (enExample)
JP (1) JP4078206B2 (enExample)
KR (2) KR20080041756A (enExample)
CN (1) CN1216034C (enExample)
AT (1) ATE294154T1 (enExample)
AU (1) AU2002238534C1 (enExample)
BR (1) BR0207077A (enExample)
CA (1) CA2437592A1 (enExample)
CZ (1) CZ20032132A3 (enExample)
DE (1) DE60203890T2 (enExample)
DK (1) DK1370513T3 (enExample)
EC (1) ECSP034713A (enExample)
ES (1) ES2240698T3 (enExample)
GB (1) GB0103046D0 (enExample)
HU (1) HUP0303174A3 (enExample)
IL (2) IL157241A0 (enExample)
MX (1) MXPA03007072A (enExample)
NO (1) NO20033473L (enExample)
NZ (1) NZ527300A (enExample)
PL (1) PL204812B1 (enExample)
PT (1) PT1370513E (enExample)
RU (1) RU2289570C2 (enExample)
SI (1) SI1370513T1 (enExample)
SK (1) SK9992003A3 (enExample)
WO (1) WO2002070455A1 (enExample)
ZA (1) ZA200306029B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003244633A1 (en) * 2002-07-02 2004-01-23 Novartis Ag Methods for the treatment of sinusitis
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
RU2286144C2 (ru) * 2004-12-02 2006-10-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВСиДВ СО РАСХН) Способ лечения микроспории кошек
WO2007104474A1 (en) * 2006-03-10 2007-09-20 Novartis Ag Antifungal compositions comprising (1) a salt of terbinafine with malic acid and (2) malic acid
EP2457560A1 (en) * 2006-06-14 2012-05-30 Dr Reddy's Laboratories Limited Topical compositions
RU2350343C1 (ru) * 2007-08-13 2009-03-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВС и ДВ СО Россельхозакадемии) Способ лечения микроспории кошек
EA038195B1 (ru) 2009-01-16 2021-07-22 Экселиксис, Инк. Малатная соль n-(4-{[6,7-бис-(метилокси)хинолин-4-ил]окси}фенил)-n'-(4-фторфенил)циклопропан-1,1-дикарбоксамида и ее применение для лечения рака почек и печени
CN106106449A (zh) * 2016-06-21 2016-11-16 广西中烟工业有限责任公司 特比萘芬制剂及其在提高烟叶角鲨烯含量中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507755A (en) * 1967-10-17 1970-04-21 Bayer Ag Process for the purification of acrylonitrile by distillation with side stream withdrawal and decantation
US4276125A (en) 1979-02-02 1981-06-30 Asahi Kasei Kogyo Kabushiki Kaisha Process for purification of crude olefinically unsaturated nitrile and condenser useful for same process
US4269667A (en) 1979-08-02 1981-05-26 Standard Oil Company Acrylonitrile purification by extractive distillation
CY1410A (en) * 1979-08-22 1988-04-22 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
KR850001603B1 (ko) 1980-12-03 1985-10-24 아사히 가세이 고오교오 가부시기가이샤 불포화 니트릴의 제조법
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
NZ227042A (en) * 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US6005001A (en) 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5461068A (en) * 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
PL335934A1 (en) 1997-03-31 2000-05-22 Johnson & Johnson Consumer Solvent system of increased penetration into pharmaceutical compounds
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
WO1999049895A2 (en) 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
RU2224523C2 (ru) * 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
JP2000053681A (ja) 1998-08-10 2000-02-22 Sankyo Co Ltd 三環性複素環化合物を含有する抗菌剤
WO2001028976A1 (en) * 1999-10-22 2001-04-26 Richter Gedeon Vegyészeti Gyár Rt. Process for preparing a substituted allylamine derivative and the salts thereof
GB0014448D0 (en) 2000-06-13 2000-08-09 Novartis Ag Organic compounds
JP4899139B2 (ja) 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物
JP4803511B2 (ja) 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物

Also Published As

Publication number Publication date
JP2004523567A (ja) 2004-08-05
IL157241A (en) 2009-06-15
US7488759B2 (en) 2009-02-10
NZ527300A (en) 2005-02-25
JP4078206B2 (ja) 2008-04-23
DE60203890T2 (de) 2006-01-19
ECSP034713A (es) 2003-09-24
RU2289570C2 (ru) 2006-12-20
EP1370513B1 (en) 2005-04-27
CA2437592A1 (en) 2002-09-12
HK1060876A1 (en) 2004-08-27
PL204812B1 (pl) 2010-02-26
ZA200306029B (en) 2004-06-28
CN1216034C (zh) 2005-08-24
BR0207077A (pt) 2004-01-20
KR20080041756A (ko) 2008-05-13
SI1370513T1 (en) 2005-10-31
KR20030077606A (ko) 2003-10-01
NO20033473L (no) 2003-09-17
HUP0303174A3 (en) 2008-03-28
ATE294154T1 (de) 2005-05-15
RU2003126176A (ru) 2005-03-10
ES2240698T3 (es) 2005-10-16
PT1370513E (pt) 2005-08-31
DE60203890D1 (de) 2005-06-02
AU2002238534B2 (en) 2005-09-29
US20040147603A1 (en) 2004-07-29
KR100859609B1 (ko) 2008-09-23
SK9992003A3 (en) 2004-01-08
MXPA03007072A (es) 2003-11-18
NO20033473D0 (no) 2003-08-05
CN1491206A (zh) 2004-04-21
CZ20032132A3 (cs) 2003-10-15
HUP0303174A2 (hu) 2003-12-29
GB0103046D0 (en) 2001-03-21
WO2002070455A1 (en) 2002-09-12
IL157241A0 (en) 2004-02-19
US20070088084A1 (en) 2007-04-19
EP1370513A1 (en) 2003-12-17
AU2002238534C1 (en) 2006-04-13
PL362554A1 (en) 2004-11-02

Similar Documents

Publication Publication Date Title
HUS2000011I1 (hu) A 2,4-pirimidin-diamin vegyületek elõgyógyszerei és alkalmazásuk
SE0302811D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
HRP20120323T1 (en) Diarylhydantoin compounds
ECSP034850A (es) Sal citrato de 5, 8, 14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma
NO20041493L (no) Kjemiske forbindelser.
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
UA91002C2 (ru) 7-фенилалкилзамещенные 2-хинолиноны и 2-хиноксалиноны как ингибиторы поле(адф-рибоза)полимеразы
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
ECSP044999A (es) Agentes antidiabeticos
PT1791571E (pt) Péptidos radiofluorados
ATE511352T1 (de) Antimikrobielle zusammensetzungen
SV2003000995A (es) Nuevas arilsulfonamidas como agentes antivirales ref. lea35214-sv
AR061628A1 (es) Composicion herbicida de fenoxialcanoato y metodo de preparacion y uso
NO20033473L (no) Eplesyreaddisjonssalter av terbinafin
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
TW200744612A (en) New combination
WO2011009075A3 (en) Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
DK1970372T3 (da) Salte af 9-oxoacridin-10-eddikesyre med 1-alkylamino-1-deoxy-polyoler
EP1845780A4 (en) USES OF METHYLPHENIDATE DERIVATIVES
WO2006023586A3 (en) Guanylhydrazone compounds, compositions, methods of making and using
ATE374751T1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
SV2003001058A (es) Agentes antibacterianos pca494-01